CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹48 Cr | ₹37 Cr | ₹32 Cr | ₹32 Cr | ₹54 Cr |
What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹48 Cr |
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹54 Cr |
How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹48 Cr | 26.96 | |
| Mar2025 | ₹37 Cr | 17.43 | |
| Mar2024 | ₹32 Cr | -0.71 | |
| Mar2023 | ₹32 Cr | -40.93 | |
| Mar2022 | ₹54 Cr | - | |
Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹16,485.0 Cr | 9% | 22.4% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 9% |
22.4% |
-3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses